Breast Lobular Carcinoma — Trials

Breast Lobular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

81 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 15
Ph III recruiting: 0
Growth YoY: —
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02961790	Oxybutynin Chloride in Managing Hot Flashes	completed	Phase 3	150	Academic and Community Cancer Research UnitedOTHER	1	Jan 18, 2020	clinicaltrials

Data updated 23 days agoSource updated Jan 18, 2020source: clinicaltrials